A dose-escalation-study evaluating the toxicity and therapeutic efficacy of I-131 labelled chimeric antibody CHT-25 in patients with IL-2 expressing lymphomas. Preliminary results
BRITISH JOURNAL OF CANCER（2004）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要